Medicare, price increases spur higher profits for drugmakers
The Medicare Part D program has led to an increase in prescriptions, despite many drugs carrying higher prices than in previous years. Major drugmakers are reporting higher profits as the U.S. market accounts for an increasing percentage of company sales and profits. VIA he New York Times
The Medicare Part D program has led to an increase in prescriptions, despite many drugs carrying higher prices than in previous years. Major drugmakers are reporting higher profits as the U.S. market accounts for an increasing percentage of company sales and profits. VIA he New York Times
